Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease

Completed · Phase 3

Conditions studied: Cardiac Toxicity, Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs, such as dexrazoxane, may protect normal cells from the side effects of chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy with or without dexrazoxane in treating children who have Hodgkin's disease.

Key facts

Study ID
NCT00005578
Run by
Children's Oncology Group
People needed
219
Starts
1997-03-01
Expected to finish
2008-06-01
Last updated by the study team
2014-07-24

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.